ATE367824T1 - Faktor xiii in kombination mit faktor ix zur behandlung von hämophilie b - Google Patents

Faktor xiii in kombination mit faktor ix zur behandlung von hämophilie b

Info

Publication number
ATE367824T1
ATE367824T1 AT01993470T AT01993470T ATE367824T1 AT E367824 T1 ATE367824 T1 AT E367824T1 AT 01993470 T AT01993470 T AT 01993470T AT 01993470 T AT01993470 T AT 01993470T AT E367824 T1 ATE367824 T1 AT E367824T1
Authority
AT
Austria
Prior art keywords
factor
hemophilia
treatment
combination
xiii
Prior art date
Application number
AT01993470T
Other languages
English (en)
Inventor
Jan Ohrstrom
Lynn Rose
Paul Bishop
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Application granted granted Critical
Publication of ATE367824T1 publication Critical patent/ATE367824T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT01993470T 2000-11-10 2001-11-08 Faktor xiii in kombination mit faktor ix zur behandlung von hämophilie b ATE367824T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24736200P 2000-11-10 2000-11-10

Publications (1)

Publication Number Publication Date
ATE367824T1 true ATE367824T1 (de) 2007-08-15

Family

ID=22934628

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01993470T ATE367824T1 (de) 2000-11-10 2001-11-08 Faktor xiii in kombination mit faktor ix zur behandlung von hämophilie b

Country Status (8)

Country Link
EP (1) EP1351706B1 (de)
JP (1) JP2004513150A (de)
AT (1) ATE367824T1 (de)
AU (1) AU2002226004A1 (de)
CA (1) CA2429018A1 (de)
DE (1) DE60129599T2 (de)
ES (1) ES2288524T3 (de)
WO (1) WO2002038167A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1784415A2 (de) 2004-08-27 2007-05-16 Novo Nordisk Health Care AG Reinigung von faktor xiii-polypeptiden aus biologischen materialien
ATE540974T1 (de) 2004-11-23 2012-01-15 Zymogenetics Inc Reinigung des rekombinanten menschlichen faktors xiii

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2423988A (en) * 1987-08-17 1989-03-09 Liposome Company, Inc., The A sponge enzyme having transglutaminase-like activity
CA2406583A1 (en) * 2000-05-10 2001-11-15 Novo Nordisk A/S Pharmaceutical composition comprising a factor viia and a factor xiii

Also Published As

Publication number Publication date
ES2288524T3 (es) 2008-01-16
CA2429018A1 (en) 2002-05-16
EP1351706B1 (de) 2007-07-25
EP1351706A2 (de) 2003-10-15
AU2002226004A1 (en) 2002-05-21
DE60129599T2 (de) 2008-04-17
WO2002038167A3 (en) 2002-08-22
WO2002038167A2 (en) 2002-05-16
DE60129599D1 (de) 2007-09-06
JP2004513150A (ja) 2004-04-30

Similar Documents

Publication Publication Date Title
DE60236413D1 (de) Inhibitoren von hmgb1 zur behandlung von gewebekrankheiten
DE60031396D1 (de) Zubereitung zur behandlung von einer neurologischen erkrankung
DE60204966D1 (de) Verwendung von cyclopamine zur Herstellung eines Arzneimittels zur Behandlung von Psoriasis
CY1109650T1 (el) Χρηση νευρικων νηματικων πρωτεϊνων για την αντιμετωπιση νεοπλασιων
ATE444086T1 (de) Therapeutische zusammensetzungen und verfahren zur behandlung von periodontitis mit entzündunshemmenden mitteln
DE69116380D1 (de) Pharmazeutische zubereitung zur behandlung verlängerter gerinnungszeit
ATE368455T1 (de) Verwendung von (+)-tramadol, o-demethyltramadol, o-desmethyl-n-mono-desmethyl-tramadol zur therapie der harninkontinenz
DE69829202D1 (de) Verwendung von mirtazapine zur herstellung eines medikaments zur behandlung von schlafapnoen
ID24184A (id) Obat untuk perawatan disfungsi ereksi
ATE142875T1 (de) Methode zur behandlung von haarausfall
ATE359808T1 (de) Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma
DE50100833D1 (de) Verwendung von 2-methyl-thiazolidin-2,4-dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen
ATE367824T1 (de) Faktor xiii in kombination mit faktor ix zur behandlung von hämophilie b
ATE294584T1 (de) Verwendung von desoxypeganin zur behandlung von alzheimerischer demenz
DE602004016126D1 (de) Aplidine zur behandlung von multiplem myelom
ATE344662T1 (de) Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen
DE60216292D1 (de) Calciumtrifluoracetat mit zytotoxischer wirkung
ATE291425T1 (de) R-eliprodil zur behandlung von glaucoma
DE60128130D1 (de) Verwendung des blutgerinnungsfaktors xiii für die behandlung der hämophilie a
ATE262362T1 (de) Verwendung von cyamemazin zur behandlung von entwöhnungserscheinungen der benzodiazepinbehandlung
DE60102812D1 (de) Verwendung von thioamidoxazolidinonen zur behandlung von knochenresorption und osteoporose
ATE228840T1 (de) Neue verwendung von ropivacain zur schmerzbehandlung
ATE236633T1 (de) Topische verwendung von loperamid zur behandlung mikrobieller infektionen
DE50008353D1 (de) Zahnschleifkörper zur behandlung eines engstandes von zähnen
DE69922174D1 (de) Biomaterial zur behandlung von zahnfäule

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties